early-stage biotech company building an immunotherapy platform and companion diagnostics for aggressive, hypoxic tumors
Mabpro Therapeutics has raised $160K in total funding. The most recent round was Angel. The last funding was announced in February 2023.
Mabpro Therapeutics is headquartered in Bratislava, Slovakia (Slovak Republic).
early-stage biotech company building an immunotherapy platform and companion diagnostics for aggressive, hypoxic tumors
Mabpro Therapeutics is at the Angel stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mabpro Therapeutics — Funding & Investors." VCBacked, February 16, 2023, https://www.vcbacked.co/company/mabpro-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Mabpro Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mabpro-therapeutics
{{cite web |title=Mabpro Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mabpro-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated